Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
CT1812 Alzheimer's Disease (Phase 1/2) Cognition Therapeutics Inc. Amyloid-Related Small Molecule